The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Chou William | PRESIDENT AND CEO, Director | Grant(A) | 58K | — | $0 |
| Mar 16, 2026 | Borthwick Kathleen | CFO | Grant(A) | 16K | — | $0 |
| Jan 8, 2026 | Chou William | PRESIDENT AND CEO, Director | Option exercise(M) | 10K | — | — |
| Jan 8, 2026 | Chou William | PRESIDENT AND CEO, Director | Sell(S) | 4K | $18.44 | $75K |
| Jan 8, 2026 | Chou William | PRESIDENT AND CEO, Director | Option exercise(M) | 10K | — | $0 |
| Jan 8, 2026 | Borthwick Kathleen | CFO | Option exercise(M) | 5K | — | — |
| Jan 8, 2026 | Borthwick Kathleen | CFO | Sell(S) | 2K | $18.44 | $38K |
| Jan 8, 2026 | Borthwick Kathleen | CFO | Option exercise(M) | 5K | — | $0 |
| Sep 15, 2025 | Nichols Weston | 10% Owner | Buy(P) | 12K | $6.99 | $83K |
| Sep 12, 2025 | Nichols Weston | 10% Owner | Buy(P) | 20K | $6.99 | $138K |
| Sep 11, 2025 | Nichols Weston | 10% Owner | Buy(P) | 325 | $6.96 | $2K |
| Jul 24, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 66K | $5.71 | $379K |
| Jul 23, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 49K | $5.74 | $283K |
| Jul 22, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 13K | $5.44 | $71K |
| Jun 26, 2025 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 213K | $0.33 | $70K |
| Jun 25, 2025 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 139K | $0.33 | $46K |
| Jun 24, 2025 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 232K | $0.35 | $81K |
| May 28, 2025 | Kassberg Thomas Richard | Director | Grant(A) | 144K | — | $0 |
| May 28, 2025 | Sondhi Dolan | Director | Grant(A) | 202K | — | $0 |
| May 28, 2025 | Islam Saqib | Director | Grant(A) | 202K | — | $0 |
| May 28, 2025 | Porter Derrell | Director | Grant(A) | 202K | — | $0 |
| May 28, 2025 | Countouriotis Athena | Director | Grant(A) | 202K | — | $0 |
| May 28, 2025 | Gowen Maxine | Director | Grant(A) | 202K | — | $0 |
| May 28, 2025 | Kapadia Sandip | Director | Grant(A) | 202K | — | $0 |
| Apr 24, 2025 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 68K | $0.32 | $22K |
| Apr 23, 2025 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 89K | $0.34 | $30K |
| Apr 22, 2025 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 78K | $0.34 | $27K |
| Apr 17, 2025 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 77K | $0.33 | $25K |
| Apr 16, 2025 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 62K | $0.33 | $20K |
| Apr 15, 2025 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 10K | $0.38 | $4K |
| Mar 15, 2025 | Cale Edgar B. | GC & CORPORATE SECRETARY | Grant(A) | 278K | — | $0 |
| Mar 15, 2025 | Chou William | PRESIDENT AND CEO, Director | Grant(A) | 780K | — | $0 |
| Mar 15, 2025 | Borthwick Kathleen | CFO | Grant(A) | 278K | — | $0 |
| Feb 11, 2025 | Borthwick Kathleen | CFO | Sell(S) | 3K | $0.53 | $2K |
| Feb 10, 2025 | Borthwick Kathleen | CFO | Option exercise(M) | 8K | — | — |
| Feb 10, 2025 | Borthwick Kathleen | CFO | Option exercise(M) | 8K | — | $0 |
| Jan 15, 2025 | Chou William | PRESIDENT AND CEO, Director | Grant(A) | 20K | — | $0 |
| Jan 15, 2025 | Borthwick Kathleen | CFO | Grant(A) | 10K | — | $0 |
| Jan 14, 2025 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 79K | $0.60 | $47K |
| Jan 13, 2025 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 18K | $0.64 | $12K |
| Jan 10, 2025 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 126K | $0.66 | $83K |
| Jan 8, 2025 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 75K | $0.68 | $51K |
| Jan 7, 2025 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 53K | $0.71 | $37K |
| Jan 6, 2025 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 19K | $0.77 | $15K |
| Dec 27, 2024 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 374K | $0.65 | $243K |
| Dec 20, 2024 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 230K | $0.60 | $138K |
| Dec 11, 2024 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 80 | $0.80 | $64 |
| Dec 10, 2024 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 8K | $0.80 | $6K |
| Dec 9, 2024 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 54K | $0.84 | $46K |
| Dec 6, 2024 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 21K | $0.82 | $17K |
| Dec 4, 2024 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 76K | $0.79 | $60K |
| Nov 27, 2024 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 29K | $0.67 | $20K |
| Nov 26, 2024 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 167K | $0.71 | $119K |
| Nov 25, 2024 | Lynx1 Capital Management LP | 10% Owner | Buy(P) | 260K | $0.56 | $146K |
| Sep 30, 2024 | Kassberg Thomas Richard | Director | Grant(A) | 174K | — | $0 |
| Sep 30, 2024 | Cale Edgar B. | GC & CORPORATE SECRETARY | Grant(A) | 50K | — | $0 |
| Sep 19, 2024 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 39K | $0.71 | $28K |
| Sep 18, 2024 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 26K | $0.73 | $19K |
| Sep 17, 2024 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 111K | $0.73 | $81K |
| Sep 16, 2024 | OrbiMed Capital GP VII LLC | 10% Owner | Sell(S) | 63K | $0.74 | $47K |
| May 21, 2024 | Porter Derrell | Director | Grant(A) | 48K | — | $0 |
| May 21, 2024 | Sondhi Dolan | Director | Grant(A) | 39K | — | $0 |
| May 21, 2024 | Islam Saqib | Director | Grant(A) | 48K | — | $0 |
| May 21, 2024 | Kapadia Sandip | Director | Grant(A) | 48K | — | $0 |
| May 21, 2024 | Gowen Maxine | Director | Grant(A) | 48K | — | $0 |
| May 21, 2024 | Countouriotis Athena | Director | Grant(A) | 48K | — | $0 |
| Mar 15, 2024 | Cale Edgar B. | GC & CORPORATE SECRETARY | Grant(A) | 203K | — | $0 |
| Mar 15, 2024 | Chou William | PRESIDENT AND CEO, Director | Grant(A) | 575K | — | $0 |
| Mar 15, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | Grant(A) | 203K | — | $0 |
| Mar 15, 2024 | Borthwick Kathleen | CFO | Grant(A) | 227K | — | $0 |
| Feb 13, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | Sell(S) | 2K | $0.97 | $2K |
| Feb 13, 2024 | Borthwick Kathleen | SVP, INTERIM CFO | Sell(S) | 1K | $0.97 | $1K |
| Feb 10, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | Option exercise(M) | 5K | — | — |
| Feb 10, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | Option exercise(M) | 5K | — | $0 |
| Feb 10, 2024 | Borthwick Kathleen | SVP, INTERIM CFO | Option exercise(M) | 4K | — | — |
| Feb 10, 2024 | Borthwick Kathleen | SVP, INTERIM CFO | Option exercise(M) | 4K | — | $0 |
| Jan 2, 2024 | Cale Edgar B. | GC & Corporate Secretary | Sell(S) | 16K | $0.91 | $14K |
| Jan 2, 2024 | Borthwick Kathleen | SVP, Interim CFO | Sell(S) | 11K | $0.91 | $10K |
| Jan 2, 2024 | Forman Mark S | Chief Medical Officer | Sell(S) | 16K | $0.91 | $14K |
| Dec 31, 2023 | Cale Edgar B. | GC & Corporate Secretary | Option exercise(M) | 50K | — | — |
| Dec 31, 2023 | Cale Edgar B. | GC & Corporate Secretary | Option exercise(M) | 50K | — | $0 |
| Dec 31, 2023 | Borthwick Kathleen | SVP, Interim CFO | Option exercise(M) | 30K | — | — |
| Dec 31, 2023 | Borthwick Kathleen | SVP, Interim CFO | Option exercise(M) | 30K | — | $0 |
| Dec 31, 2023 | Forman Mark S | Chief Medical Officer | Option exercise(M) | 50K | — | — |
| Dec 31, 2023 | Forman Mark S | Chief Medical Officer | Option exercise(M) | 50K | — | $0 |
| Jul 28, 2023 | Borthwick Kathleen | SVP, Interim CFO | Grant(A) | 20K | — | $0 |
| Jul 28, 2023 | King Simona | Chief Financial Officer | Option exercise(M) | 31K | — | $0 |
| Jul 28, 2023 | King Simona | Chief Financial Officer | Sell(S) | 11K | $0.88 | $10K |
| Jul 28, 2023 | King Simona | Chief Financial Officer | Option exercise(M) | 31K | — | $0 |
| Jul 27, 2023 | Sondhi Dolan | Director | Grant(A) | 48K | — | $0 |
| Jun 28, 2023 | Orbimed Advisors LLC | 10% Owner | Buy(P) | 575K | $0.84 | $483K |
| Jun 27, 2023 | Orbimed Advisors LLC | 10% Owner | Buy(P) | 617K | $0.84 | $519K |
| Feb 10, 2022 | Forman Mark S | CHIEF MEDICAL OFFICER | Grant(A) | 15K | — | $0 |
| Feb 10, 2022 | Forman Mark S | CHIEF MEDICAL OFFICER | Grant(A) | 25K | — | $0 |
| Aug 16, 2021 | Forman Mark S | CHIEF MEDICAL OFFICER | Grant(A) | 130K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).